Director, Clinical Research — RNAi Neurology/Hematology

Alnylam Pharmaceuticals, Inc.; Schweiz; Hybrid; CHF 180,000 - 250,000; Full time

Job summary

Alnylam Pharmaceuticals, Inc. seeks an imaginative physician drug developer to lead clinical research in neurology and hematology, shaping RNAi therapeutics across rare genetic and common diseases.

The Director, Clinical Research, will drive progress and provide a leadership voice in global regulatory strategy and external engagements. The role centers on leading the plasminogen program from Phase 2 to Phase 3, with matrix collaboration across Regulatory, Biostatistics, Clinical Operations,

Qualifications

• MD with strong research background or MD PhD with best of class clinical/research training as shown through research support and peer-reviewed publications.
• Board Certification (or equivalent) in neurology is desirable
• 3+ years industry experience or equivalent clinical academic research experience
• Familiarity with clinical research concepts including biostatistics and regulatory guidelines
• Ability to present complex medical concepts clearly in writing and speaking

Responsibilities

• Be a subject matter expert for the relevant disease areas.
• Provide strategic leadership for the clinical program.
• Develop creative approaches to drug development and drive regulatory approvals.
• Oversee trial conduct and safety.
• Collaborate with Preclinical, Regulatory Affairs and Medical Affairs for integrated product development plans.
• Ensure timely delivery of timelines and deliverables.
• Review and sign off on all controlled documents (protocols, investigator brochures, consent forms).
• Influence internal and external audiences in a high-impact setting.

Skills

MD/MD-PhD

Neurology specialization

Clinical leadership

Regulatory knowledge

Biostatistics understanding

Education

MD/MD-PhD with neurology train

Board Certification in neurology

Job description

Alnylam Pharmaceuticals, Inc. seeks an imaginative physician drug developer to lead clinical research in neurology and hematology, shaping RNAi therapeutics across rare genetic and common diseases.

The Director, Clinical Research, will drive progress and provide a leadership voice in global regulatory strategy and external engagements. The role centers on leading the plasminogen program from Phase 2 to Phase 3, with matrix collaboration across Regulatory, Biostatistics, Clinical Operations,